Search results
Aug 24, 2021 · The Boston genetic engineering company Ginkgo Bioworks and its CEO, Jason Kelly, have been spectacularly successful selling a story: that synthetic biology will transform the manufacture of ...
Jason Kelly is a baseball coach and former player, who is the currently the pitching coach of the Texas A&M Aggies. He played college baseball for the Cal Poly Mustangs, the Cuesta Cougars and the Missouri Valley Vikings .
Jun 30, 2024 · BRYAN, Texas (KBTX) - Texas A&M baseball is set to hire Washington head coach Jason Kelly as its next pitching coach, as first reported by The Eagle.
Dr. Jason Kelly is the co-founder and CEO of Ginkgo Bioworks, the leading horizontal platform for cell programming. Headquartered in Boston, Ginkgo is a synthetic biology company that enables customers across industries to outsource microbial, fungal, and mammalian cell engineering to Ginkgo’s automated laboratories.
Jun 30, 2024 · University of Washington head coach Jason Kelly, who spent the last two seasons at the helm of the Huskies' program, is now set to go to Aggieland as Texas A&M's pitching coach.
Feb 17, 2023 · Jason Kelly will chair the commission while heading Ginkgo, with a roughly 6% stake in the company currently valued at over $100 million.
Apr 11, 2024 · Read our letter to the world. “With help from software-directed robots, 10 technicians in [Ginkgo’s] factory can equal the output of 50 to 100 scientists working by hand at a bench.”.
Jun 3, 2020 · Jason Kelly is the author of The 3% Signal (3Sig), which introduced the technique that pushed dollar-cost averaging aside as the stock market’s new best practice. His nine other books include The Neatest Little Guide to Stock Market Investing, a BusinessWeek best seller now in its fifth edition; and its companion volume, Stock Market Contest.
Dr. Jason Kelly is the co-founder and CEO of Ginkgo Bioworks. Ginkgo is a synthetic biology company headquartered in Boston, MA that programs cells for customers in the chemical, pharmaceutical, food and energy industries.
Dr. Jason Kelly is the co-founder and CEO of Ginkgo Bioworks, the leading horizontal platform for cell programming. Headquartered in Boston, Ginkgo is a synthetic biology company that enables customers across industries to program cells as easily as we can program computers.
